Pfizer 4Q08 4Q Revenues: $12.3 billion (-4%) 4Q Earnings: $266 million (-96%) FY Revenues: $48.3 billion (flat) FY Earnings: $8.1 billion (flat) Comments: Generic losses continued to dent Pfizer’s sales: Zyrtec, Camptosar and Norvasc revenues dropped $515 million from 4Q07 (and $2.6 billion for FY08). U.S. drug revenues dropped 8% to $5.3 billion for the quarter. A strengthening dollar hurt international sales, which dropped 1% to $7.1 billion. New product sales dropped 4% i...